Study to Evaluate and Explore Scales for Repetitive and Restricted Behaviors and Digital Biomarkers in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)
Latest Information Update: 31 Jan 2025
At a glance
- Drugs Alogabat (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- Sponsors Roche
- 13 Jun 2024 Status changed from active, no longer recruiting to completed.
- 01 Mar 2024 Status changed from recruiting to active, no longer recruiting.
- 04 Jan 2024 Planned End Date changed from 22 Dec 2023 to 17 May 2024.